Company

Vision

Aible Therapeutics envisions a world where people can live free from the fear of dementia
through the fusion of innovative ideas and AI technology

We are developing an integrated digital platform to prevent, diagnose, manage, and treat
neuropsychiatric disorders, aiming to help more people benefit from our service

Aible in Media

Thumbnail
Thumbnail
Thumbnail

History

2024

AugPreparing for collaborative PoCs with a global home appliance company and a leading domestic pharmaceutical company.

Aug‘Spick’ U.S. patent registered

JunBegan confirmatory clinical trials for medical device certification at 8 hospitals

MaySelected for the MUST. CONNECT 2024 Global AC Program

AprSecured a 3-year R&D project from the Korea Dementia Research Center; began developing a multi-biomarker-based dementia screening solution

AprLaunched regular 'Cognimo' classes at local senior welfare centers

AprLaunched paid services for ‘Spick’ at local smart senior centers

FebSigned an MOU with Gwangju Metropolitan City to establish an AI ecosystem

JanCompleted the first clinical trial in Taiwan (331 participants)

2023

DecAcquired KOLAS V&V certification for ‘Spick’

DecReceived approval from the K-FDA for the confirmatory clinical trial protocol for medical device certification

OctSigned an NDA with a leading domestic pharmaceutical company

OctLaunched paid services for ‘Spick’ at senior daycare centers

SepSecured a 2-year R&D project from the Ministry of SMEs and Startups; began developing a drawing-based dementia screening solution.

AugSigned an NDA with a global home appliance company.

Aug‘Spick’ Taiwan patent registered

JunBegan clinical trials in Taiwan for the collection of standard Mandarin speech data

Jun‘Child and adolescent ADHD screening technology based on eye-tracking’ domestic patent registered

May‘Cognimo’ domestic patent registered

AprAcquired GS certification, Grade 1, for ‘Spick’

Apr‘Spick’ advanced version patent registered in South Korea

MarSelected for the Shinhan Square Bridge 2023 AC Progra

MarDrawing-based dementia diagnosis’ patent registered in South Korea

2022

DecSecured additional investment

DecStarted clinical trials for ‘Cognimo’

SepBegan PoC (Proof of Concept) for ‘Spick’ at senior daycare centers

JulSelected for the Daekyo x Kyobo Life Insurance Age-Tech Wave Open Innovation Program

JunAcquired medical device GMP certification for ‘Spick’ from the Ministry of Food and Drug Safety

AprSecured a 3-year R&D project from the Ministry of Health and Welfare; began developing a mental health monitoring and intervention system for children and adolescents

MarSecured a 1-year R&D project from the Ministry of SMEs and Startups; began developing 'Cognimo' for dementia prevention and management DTx

2021

DecSelected for the Taiwan BE Health Ventures Global AC Program

OctSecured seeding investment

Jul‘Spick’ patent registered in South Korea

MaySelected for the Korea Sports Promotion Foundation's Sports Industry AC Program

AprAdvanced to Top 6 in D.Camp IR pitch

MarWon the Grand Prize (Minister’s Award) in the Ministry of Science and ICT’s ‘Innovation ICT Idea Contest’

FebEstablished Aible Therapeutics Co., Ltd.

2019 ~ 2020

Collected 1,300 speech data samples and completed the dementia diagnosis algorithm

2018

Began research on speech-based dementia diagnosis

Co-founders

Kim, Hyungjun (CEO)

Prof. Kim, Woojun (CSO)

The Catholic Univ. Of Korea Seoul St.Mary's Hospital

Cheon, Hosang (CXO)

UI·UX Expert

Dr. Kim, Jaewon (CTO)

Seoul National University Hospital

Prof. Lim, Junsik (CTO)

Gachon University

Advisory Group

Dr. Yang, Dongwon

  • Seoul St. Mary's Hospital
  • Director of Mapo-gu
    Dementia Care Center

Dr. Shim, Yongsoo

  • Eunpyeong St. Mary's Hospital
  • Director of Eunpyeong-gu
    Dementia Care Center

Dr. Yoon, Bora

  • Seoul St. Mary's Hospital
  • Health and welfare Minister's
    Award Recipient

Dr. Hong, Yunjung

  • Uijeongbu St. Mary's Hospital
  • 2020 Paper Award, Korean
    Dementia Association

Dr. Jihye, Park

  • Eunpyeong St. Mary's Hospital
  • Advisor of National
    Pension Service